Phase II study of biweekly irinotecan and mitomycin C combination therapy in patients with fluoropyrimidine-resistant advanced colorectal cancer
作者： Tadamichi Denda , Tomonori Ambo , Atsushi Ohtsu , Yasuhide Yamada , Kuniaki Shirao
DOI: 10.1007/S00280-003-0604-1
关键词:
摘要: Purpose Experimental studies have shown that mitomycin C (MMC) acts synergistically with irinotecan. We evaluated the antitumor activity and toxicity of a combination irinotecan MMC in patients metastatic colorectal cancer resistant to fluoropyrimidines.
springer.com
sci-hub.se 参考文章(19)
A Wakui, T Taguchi, Y Sakata, M Yoshino, Y Shimada, K Futatsuki, I Nakao, N Ogawa, M Kambe, [Late phase II study of irinotecan hydrochloride (CPT-11) in advanced gastric cancer. CPT-11 Gastrointestinal Cancer Study Group]. Gan to kagaku ryoho. Cancer & chemotherapy. ,vol. 21, pp. 1033- 1038 ,(1994)
P Rougier, R Bugat, J Y Douillard, S Culine, E Suc, P Brunet, Y Becouarn, M Ychou, M Marty, J M Extra, J Bonneterre, A Adenis, J F Seitz, G Ganem, M Namer, T Conroy, S Negrier, Y Merrouche, F Burki, M Mousseau, P Herait, M Mahjoubi, Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy. Journal of Clinical Oncology. ,vol. 15, pp. 251- 260 ,(1997) , 10.1200/JCO.1997.15.1.251
M Fukuoka, H Niitani, A Suzuki, M Motomiya, K Hasegawa, Y Nishiwaki, T Kuriyama, Y Ariyoshi, S Negoro, N Masuda, A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer. Journal of Clinical Oncology. ,vol. 10, pp. 16- 20 ,(1992) , 10.1200/JCO.1992.10.1.16
Yolanda Madarnas, Peter Webster, Anne Marie Shorter, Georg A Bjarnason, Irinotecan-associated pulmonary toxicity. Anti-Cancer Drugs. ,vol. 11, pp. 709- 713 ,(2000) , 10.1097/00001813-200010000-00007
Philippe Rougier, Eric Van Cutsem, Emilio Bajetta, Norbert Niederle, Kurt Possinger, Roberto Labianca, Matilde Navarro, Rudolf Morant, Harry Bleiberg, Jacques Wils, Lucile Awad, Patrice Herait, Christian Jacques, Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer The Lancet. ,vol. 352, pp. 1407- 1412 ,(1998) , 10.1016/S0140-6736(98)03085-2
Jaap Verweij, Thea van Zanten, Tjeu Souren, Richard Golding, Herbert M. Pinedo, Prospective study on the dose relationship of mitomycin C-induced interstitial pneumonitis. Cancer. ,vol. 60, pp. 756- 761 ,(1987) , 10.1002/1097-0142(19870815)60:4<756::AID-CNCR2820600408>3.0.CO;2-H
Pasquale Comella, Maria Biglietto, Rossana Casaretti, Luigi De Lucia, Antonio Avallone, Luigi Maiorino, Liberato Di Lullo, Giuseppe De Cataldis, Flavia Rivellini, Giuseppe Comella, Irinotecan and mitomycin C in 5-fluorouracil-refractory colorectal cancer patients. A phase I/II study of the Southern Italy Cooperative Oncology Group. Oncology. ,vol. 60, pp. 127- 133 ,(2001) , 10.1159/000055309
D. Machover, E. Diaz-Rubio, A. de Gramont, A. Schilf, J.-J. Gastiaburu, S. Brienza, M. Itzhaki, G. Metzger, D. N'Daw, J. Vignoud, A. Abad, E. François, E. Gamelin, M. Marty, J. Sastre, J.-F. Seitz, M. Ychou, Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines Annals of Oncology. ,vol. 7, pp. 95- 98 ,(1996) , 10.1093/OXFORDJOURNALS.ANNONC.A010489
Yasuhiko Kano, Kenichi Suzuki, Miyuki Akutsu, Keiichi Suda, Yoshiharu Indue, Minoru Yosnida, Shinobu Sakamoto, Yasusada Miura, Effects of CPT-11 in combination with other anti-cancer agents in culture. International Journal of Cancer. ,vol. 50, pp. 604- 610 ,(1992) , 10.1002/IJC.2910500420
John A. Conti, Nancy E. Kemeny, Leonard B. Saltz, A. McKenzie André, Dennis D. Grossano, Joseph R. Bertino, Continuous infusion fluorouracil/leucovorin and bolus mitomycin-C as a salvage regimen for patients with advanced colorectal cancer Cancer. ,vol. 75, pp. 769- 774 ,(1995) , 10.1002/1097-0142(19950201)75:3<769::AID-CNCR2820750304>3.0.CO;2-5